Home
Sakar Healthcare Ltd Share Price History
Sakar Healthcare Ltd
NSE : 15 Jan, 2025
290.45-0.5 (-0.2%)
Prev Close
291.0
Open Price
292.6
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
8954
Today's High / Low
295.2 / 289.0
52 WK High / Low
479.0 / 279.9
Market Price of Sakar Healthcare Ltd
1M
1Y
3Y
5Y
Monitoring Sakar Healthcare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2020 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 6.43 |
| YoY Gr. | - |
| Net Profit (Cr.) | 10 |
| BVPS | 54.35 |
Key Financial Parameters
| Parameter | 2020 |
|---|---|
| Return on Capital Emp. % | 14.68 |
| Op. Profit Mgn % | 25.99 |
| Net Profit Mgn % | 11.59 |
| Debt to Equity % | 0.2 |
Latest Shareholding
Promoters Holdings Over Time
About Sakar Healthcare Ltd
- Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004.
- Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited.
- The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages.
- It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.
FAQs for Sakar Healthcare Ltd Share Price History
What are the key events that typically impact Sakar Healthcare Ltd's share price history?
Key events that impact Sakar Healthcare Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Sakar Healthcare Ltd's share price history?
Stock splits reduce the nominal price of Sakar Healthcare Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Sakar Healthcare Ltd?
Dividends can influence Sakar Healthcare Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Sakar Healthcare Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Sakar Healthcare Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Sakar Healthcare Ltd’s share price history?
To understand Sakar Healthcare Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
